Edition:
United Kingdom

Landec Corp (LNDC.OQ)

LNDC.OQ on NASDAQ Stock Exchange Global Select Market

12.75USD
15 Dec 2017
Change (% chg)

$0.45 (+3.66%)
Prev Close
$12.30
Open
$12.25
Day's High
$12.85
Day's Low
$12.25
Volume
82,935
Avg. Vol
16,175
52-wk High
$14.95
52-wk Low
$11.25

Summary

Name Age Since Current Position

Steven Goldby

76 2015 Independent Chairman of the Board

Molly Hemmeter

49 2015 President, Chief Executive Officer

Gregory Skinner

55 2000 Chief Financial Officer, Vice President - Finance and Administration

James Hall

53 2017 President of Lifecore

Ronald Midyett

50 2015 Chief Operating Officer

Steven Bitler

58 2002 Vice President - Corporate Technology

Deborah Carosella

2017 Director

Albert Bolles

59 2014 Independent Director

Frederick Frank

84 1999 Independent Director

Tonia Pankopf

48 2012 Independent Director

Catherine Sohn

63 2012 Independent Director

Robert Tobin

78 2004 Independent Director

Matt Glover

IR Contact Officer

Biographies

Name Description

Steven Goldby

Mr. Steven D. Goldby is Independent Chairman of the Board of the Company. Mr. Goldby has served as a director since December 2008 and is currently the Board’s Outside Lead Independent Director and a sitting member of the Audit Committee. Mr. Goldby has been a Partner at Venrock, a venture capital firm, since 2007. Mr. Goldby was Chairman and Chief Executive Officer of Symyx Technologies, Inc. (“Symyx”) from 1998 to 2007; he became the Executive Chairman in 2008, and Chairman in 2009. Before joining Symyx, Mr. Goldby served as Chief Executive Officer for more than ten years at MDL Information Systems, Inc., the enterprise software company that pioneered scientific information management. Earlier, Mr. Goldby held various management positions at ALZA Corporation, including President of Alza Pharmaceuticals. Mr. Goldby received a B.S. degree in chemistry from the University of North Carolina and a law degree from Georgetown University Law Center.

Molly Hemmeter

Ms. Molly A. Hemmeter serves as President, Chief Executive Officer of the Company. Ms. Hemmeter has served as Chief Operating Officer of the Registrant since January 2014 and previously served as Chief Commercial Officer of the Registrant from December 2010 to January 2014 and Vice President, Business Development and Global Marketing of the Registrant from June 2009 to December 2010. From July 2006 until joining the Registrant in 2009, Ms. Hemmeter was Vice President of Global Marketing and New Business Development for the Performance Materials division of Ashland, Inc., a global specialty chemicals company. Prior to joining Ashland, Inc., Ms. Hemmeter was Vice President of Strategy and Marketing for Siterra Corporation in San Francisco, a privately held company delivering on-demand software for managing real estate asset portfolios.

Gregory Skinner

Mr. Gregory S. Skinner is Chief Financial Officer, Vice President - Finance and Administration of the Company. From May 1996 to October 1999, Mr. Skinner served as Controller of the Company. From 1994 to 1996, Mr. Skinner was Controller of DNA Plant Technology and from 1988 to 1994 he was with Litton Electron Devices. Prior to joining Litton Electron Devices, Mr. Skinner was with Litton Industries, Inc. and Arthur Anderson & Company.

James Hall

Mr. James G. Hall is appointed as President of Lifecore of the subsidiary of the company effective on June 1, 2017. He is currently Vice President and General Manager of Lifecore and who has worked at Lifecore for over 18 years.

Ronald Midyett

Mr. Ronald Lane Midyett serves as Chief Operating Officer of the Company. He is no longer Vice President of the Landec Corp., since February 2008. President and Chief Executive Officer of Apio since January 2008. Mr. Midyett joined Apio in May 2005 as Chief Operating Officer. Prior to joining Apio, Mr. Midyett was Senior Vice President of Operations for Dole Fresh Vegetables. Mr. Midyett has over 20 years of technology and operations experience in the produce industry. Mr. Midyett is currently chairman of the board of directors of the United Fresh Fruit and Vegetable Association and a director of Windset Holdings 2010 Ltd., a privately held Canadian corporation.

Steven Bitler

Dr. Steven P. Bitler, Ph.D., serves as Vice President - Corporate Technology of the Company. From 1988 until March 2002, Dr. Bitler held various positions with the Company related to the Company’s polymer product development and thermal switch products. Prior to joining the Company, Dr. Bitler developed new high strength polymeric materials at SRI International.

Deborah Carosella

Ms. Deborah B. Carosella serves as Director of the Company. She is a member of the Company's Food Innovation Committee. Ms. Carosella was most recently the CEO of Madhava Natural Sweeteners, focused on innovating honey and agave-based products that provide an alternative to highly processed refined sugars and artificial sweeteners. Ms. Carosella led the transformation of Madhava, meaning "born of honey", from a base of commodity products to a broad line of value-added branded products, doubling sales and margins over the four years of her leadership. Previously, Ms. Carosella was the Senior Vice President of Innovation and a member of the Executive Operating Team at Whitewave Foods, currently in the process of being acquired by European food giant, Danone SA. Previous to Whitewave, she led the innovation efforts at Dean Foods, where she built the innovation function, capabilities and processes used at both Whitewave and Dean Foods. Prior to Dean Foods, Ms. Carosella was Vice President and General Manager as well as Vice President of Strategic Marketing and Innovation at ConAgra Foods. Accomplishments at ConAgra included driving double-digit revenue and profit growth and creating, developing and commercializing one of the company's most successful product launches in its history, which delivered over $100 million in sales in its first year. Before ConAgra, Ms. Carosella was Vice President Consumer Nutrition Brand Strategy at Monsanto Company. Ms. Carosella is a graduate of the University of Missouri.

Albert Bolles

Dr. Albert D. Bolles, Ph.D. is Independent Director of the company. He also served as Retired Executive Vice President and Chief Technical and Operations Officer, ConAgra Foods, Inc., until his retirement in August 2015. Dr. Bolles leads the Research, Quality & Innovation and Supply Chain organizations for ConAgra Foods, which is one of North America's largest packaged food companies. The company's portfolio includes iconic consumer brands such as Hunt's, Chef Boyardee and Reddi-wip, plus the largest private brand package food business in North America, and a strong commercial and foodservice business. Dr. Bolles has been with ConAgra, an $18 billion food company, since 2006 and reports directly to the CEO. Dr. Bolles has led innovation programs for multiple new products, generating incremental sales and a multi-year pipeline to sustain and advance future growth. In advancing innovation at ConAgra, Dr. Bolles developed two external scientific advisory boards comprised of nationally recognized leaders to shape strategy and create industry leadership for ConAgra in Health & Wellness and Food Safety. As an industry partner with the FDA and USDA on influencing and crafting public policy that benefits consumers, Dr. Bolles was instrumental in the passage of the Food Safety Modernization Act in 2010. Dr. Bolles holds six patents. He is a graduate of Michigan State University with a B.S. in Microbiology plus an M.S. and Ph.D. in Food Science.

Frederick Frank

Mr. Frederick Frank is Independent Director of the Company. Mr. Frank is Chairman of the Board of Evolution Life Sciences Partners. Prior to joining Evolution Partners, Mr. Frank was Chairman of the Board of Burrill Securities. Prior to joining Burrill Securities, Mr. Frank was Vice Chairman of Peter J. Solomon Company (“Solomon”). Before joining Solomon, Mr. Frank was Vice Chairman of Lehman Brothers, Inc. (“Lehman”) and Barclays Capital. Before joining Lehman as a Partner in October 1969, Mr. Frank was co-director of research, as well as Vice President and Director of Smith Barney & Co. Incorporated. During his over 50 years on Wall Street, Mr. Frank has been involved in numerous financings and merger and acquisition transactions. He serves as an advisor to the board of directors of PDL BioPharma, and was a director for the Institute for Systems Biology and Pharmaceutical Product Development, Inc. Mr. Frank is Chairman of the National Genetics Foundation and he serves on the Advisory Boards for Yale School of Organization and Management, the Massachusetts Institute of Technology Center of Biomedical Innovation and was formerly an Advisory Member of the Johns Hopkins Bloomberg School of Public Health, and the Harvard School of Public Health. He is a graduate of Yale University, received an M.B.A. from Stanford University and is a Chartered Financial Analyst.

Tonia Pankopf

Ms. Tonia Pankopf is Independent Director of the Company. Ms. Pankopf has been managing partner of Pareto Advisors, LLC since 2005. Previously, she was a senior analyst and managing director at Palladio Capital Management from January 2004 through April 2005. From 2001 to 2003, Ms. Pankopf served as an analyst and portfolio manager with P.A.W. Capital Partners, LP. Ms. Pankopf was a senior analyst and vice president at Goldman, Sachs & Co. from 1999 to 2001 and at Merrill Lynch & Co. from 1998 to 1999. Ms. Pankopf serves on the Board of Directors of TICC Capital Corp. and served on the Board of the University System of Maryland Foundation from 2006 to 2012. Ms. Pankopf is a member of the National Association of Corporate Directors and has been designated an NACD Governance Fellow in recognition of her ongoing involvement in director professionalism and engagement with the director community. Ms. Pankopf received a Bachelor of Arts degree summa cum laude from the University of Maryland and an M.S. degree from the London School of Economics.

Catherine Sohn

Dr. Catherine A. Sohn is Independent Director of the Company. Dr. Sohn brings significant industry experience in pharmaceutical and health-related sectors based on her leadership and achievements in business development and new product development for 28 years at Glaxo Smith Kline (“GSK”). Most recently, Dr. Sohn was Senior Vice President of Worldwide Business Development and Strategic Alliance for GSK’s $8 billion consumer healthcare division. Early in her career, Dr. Sohn established the U.S. vaccine business unit for SmithKline Beecham Pharmaceuticals and she subsequently led the commercialization of Paxil, which became one of GSK’s top five pharmaceutical products. Currently Dr. Sohn serves as president of Sohn Health Strategies, LLC, providing business development and new product marketing consultation to biotechnology, specialty pharmaceutical and healthcare companies. Dr. Sohn is a National Association of Corporate Directors (NACD) Governance Fellow. She has demonstrated her commitment to boardroom excellence by completing NACD’s comprehensive program of study for corporate directors. She supplements her skill sets through ongoing engagement with the director community and access to leading practices. Dr. Sohn received her Doctor of Pharmacy degree from University of California in San Francisco.

Robert Tobin

Mr. Robert G. Tobin is Independent Director of the Company. Mr. Tobin retired from his position as Chief Executive Officer of Ahold USA in 2001. Mr. Tobin has over 40 years of industry experience in the food retail and food service sectors, having served as Chairman and CEO of Stop and Shop Supermarkets. An industry leader, Mr. Tobin serves on the advisory boards of the College of Agriculture and Life Sciences and the Undergraduate Business Program at Cornell University where he received his B.S. in Agricultural Economics.

Matt Glover